Long-term follow-up of adalimumab monotherapy for rheumatoid arthritis in Japanese patients: a report of six cases

被引：0

作者：

Ichinose, Kunihiro ^{[1
]}

Origuchi, Tomoki ^{[2
]}

Kawashiri, Shin-ya ^{[1
]}

Iwamoto, Naoki ^{[1
]}

Fujikawa, Keita ^{[1
]}

Aramaki, Toshiyuki ^{[1
]}

Kamachi, Makoto ^{[1
]}

Arima, Kazuhiko ^{[1
]}

Tamai, Mami ^{[1
]}

Nakamura, Hideki ^{[1
]}

Ida, Hiroaki ^{[1
]}

Kawakami, Atsushi ^{[1
]}

Eguchi, Katsumi ^{[1
]}

机构：

[1] Nagasaki Univ, Dept Rheumatol, Unit Translat Med, Grad Sch Biomed Sci, Nagasaki 8528501, Japan

[2] Nagasaki Univ, Dept Phys Therapy, Unit Rehabil, Grad Sch Biomed Sci, Nagasaki 8528501, Japan

来源：

RHEUMATOLOGY INTERNATIONAL | 2012年 / 32卷 / 02期

关键词：

Rheumatoid arthritis (RA); Adalimumab; Long-term; DAS28-CRP; ANTITUMOR NECROSIS FACTOR; MONOCLONAL-ANTIBODY; METHOTREXATE; RISK; TUBERCULOSIS; EFFICACY; THERAPY; DISEASE; SAFETY;

D O I：

10.1007/s00296-010-1770-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We present six cases of patients with Japanese rheumatoid arthritis (RA) treated with a tumor necrosis factor (TNF)-alpha blocking agent, adalimumab as monotherapy for 220 weeks. All six patients were women, and the median age was 54.0 +/- A 7.07 years old. The median duration of the disease was 7.43 +/- A 11.1 years, and the median disease activity score (DAS28-CRP) was 5.35 +/- A 0.69. Three of six patients were able to continue to receive this treatment for 220 weeks successfully, and the DAS28-CRP decreased to 1.89 +/- A 0.75. Two patients withdrew because of lack of efficacy, and one patient withdrew because of adverse events (non-Hodgkin lymphoma). Adalimumab resulted in a sustained clinical response in RA patients during 220-week follow-up.

引用

页码：483 / 487

页数：5

共 50 条

[1] Long-term follow-up of adalimumab monotherapy for rheumatoid arthritis in Japanese patients: a report of six cases
Kunihiro Ichinose
Tomoki Origuchi
Shin-ya Kawashiri
Naoki Iwamoto
Keita Fujikawa
Toshiyuki Aramaki
Makoto Kamachi
Kazuhiko Arima
Mami Tamai
Hideki Nakamura
Hiroaki Ida
Atsushi Kawakami
Katsumi Eguchi
Rheumatology International, 2012, 32 : 483 - 487
[2] A long-term follow-up of zonisamide monotherapy
Fukushima, Katsuyuki
Seino, Masakazu
EPILEPSIA, 2006, 47 (11) : 1860 - 1864
[3] Long-term treatment of rheumatoid arthritis with adalimumab
Murdaca, Giuseppe
Spano, Francesca
Puppo, Francesco
OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2013, 5 : 43 - 49
[4] Long-Term Effectiveness of Adalimumab in Patients with Rheumatoid Arthritis: An Observational Analysis from the Corrona Rheumatoid Arthritis Registry
Pappas, Dimitrios A.
Kremer, Joel M.
Griffith, Jenny
Reed, George
Salim, Bob
Karki, Chitra
Garg, Vishvas
RHEUMATOLOGY AND THERAPY, 2017, 4 (02) : 375 - 389
[5] 5-year remission rate after the discontinuation of adalimumab in patients with rheumatoid arthritis: Long-term follow-up results of the HONOR study
Yamaguchi, Ayako
Hirata, Shintaro
Kubo, Satoshi
Fukuyo, Shunsuke
Hanami, Kentaro
Nakano, Kazuhisa
Nakayamada, Shingo
Saito, Kazuyoshi
Tanaka, Yoshiya
MODERN RHEUMATOLOGY, 2020, 30 (05) : 799 - 806
[6] Long-term follow-up of HIV-infected patients on dolutegravir monotherapy
Tebano, G.
Soulie, C.
Schneider, L.
Blanc, C.
Agher, R.
Seang, S.
Valantin, M. A.
Palich, R.
Tubiana, R.
Peytavin, G.
Marcelin, A. G.
Assoumou, L.
Katlama, C.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (03) : 675 - 680
[7] Long-term follow-up of the cervical spine with conventional radiographs in patients with rheumatoid arthritis
Blom, M.
Creemers, M. C. W.
Kievit, W.
Lemmens, J. A. M.
van Riel, P. L. C. M.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2013, 42 (04) : 281 - 288
[8] Long-term follow-up of a high-intensity exercise program in patients with rheumatoid arthritis
de Jong, Zuzana
Munneke, Marten
Kroon, Herman M.
van Schaardenburg, Dirkjan
Dijkmans, Ben A. C.
Hazes, Johanna M. W.
Vlieland, Theodora P. M. Vliet
CLINICAL RHEUMATOLOGY, 2009, 28 (06) : 663 - 671
[9] Long-term follow-up of 453 rheumatoid arthritis patients treated with methotrexate: An open, retrospective, observational study
Bologna, C
Viu, P
Picot, MC
Jorgensen, C
Sany, J
BRITISH JOURNAL OF RHEUMATOLOGY, 1997, 36 (05): : 535 - 540
[10] Incidence of and predictive factors for lung cancer in patients with rheumatoid arthritis: A retrospective long-term follow-up study
Mori, Shunsuke
Hasegawa, Mizue
Sakai, Fumikazu
Nakashima, Kouya
Nakamura, Kazuyoshi
MODERN RHEUMATOLOGY, 2024, 35 (02) : 240 - 248

← 1 2 3 4 5 →